Latest Insider Transactions at Oncocyte Corp (OCX)
This section provides a real-time view of insider transactions for Oncocyte Corp (OCX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oncocyte Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oncocyte Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Andrew J. Last Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.93%
|
-
|
|
Jun 24
2022
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.47%
|
-
|
|
Jun 24
2022
|
Melinda Griffith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Jun 24
2022
|
Jennifer L. Carter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Jun 24
2022
|
Andrew Arno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.57%
|
-
|
|
Jun 24
2022
|
Pura Vida Investments, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
99,386
-0.31%
|
$99,386
$1.04 P/Share
|
|
May 18
2022
|
Li Yu VP Cntrllr/Prncpl Acctng Offcr |
SELL
Open market or private sale
|
Direct |
8,128
-32.51%
|
$8,128
$1.14 P/Share
|
|
May 18
2022
|
Li Yu VP Cntrllr/Prncpl Acctng Offcr |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Apr 14
2022
|
Pura Vida Investments, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,931,707
+17.44%
|
$5,931,707
$1.29 P/Share
|
|
Apr 14
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 14
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,003,752
+20.45%
|
$6,003,752
$1.33 P/Share
|
|
Mar 25
2022
|
Douglas T. Ross Former CSO |
BUY
Open market or private purchase
|
Direct |
15,000
+42.47%
|
$15,000
$1.4 P/Share
|
|
Mar 17
2022
|
Gisela Paulsen Former President and COO |
BUY
Open market or private purchase
|
Direct |
16,500
+50.0%
|
$16,500
$1.2 P/Share
|
|
Mar 16
2022
|
Ronald Asbury Andrews Former CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+14.57%
|
$50,000
$1.28 P/Share
|
|
Mar 16
2022
|
Cavan M. Redmond Director |
BUY
Open market or private purchase
|
Direct |
40,000
+26.51%
|
$40,000
$1.19 P/Share
|
|
Mar 15
2022
|
Mitchell S Levine Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+22.31%
|
$25,000
$1.17 P/Share
|
|
Sep 23
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
0
|
-
|
|
Sep 23
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
573,461
+3.2%
|
$1,720,383
$3.15 P/Share
|
|
Jul 01
2021
|
Ronald Asbury Andrews Former CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,834
-6.11%
|
-
|
|
Jul 01
2021
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+20.06%
|
-
|
|
Jun 30
2021
|
Ronald Asbury Andrews Former CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,873
-11.76%
|
-
|
|
Jun 11
2021
|
Andrew J. Last Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6,993
+18.82%
|
$20,979
$3.0 P/Share
|
|
May 07
2021
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
106,221
+32.57%
|
-
|
|
Apr 28
2021
|
Mitchell S Levine Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-6.93%
|
-
|
|
Apr 28
2021
|
Mitchell S Levine Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.07%
|
-
|
|
Mar 19
2021
|
Ronald Asbury Andrews Former CEO |
BUY
Open market or private purchase
|
Direct |
11,000
+8.82%
|
$44,000
$4.79 P/Share
|
|
Feb 05
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 05
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
600,000
+3.45%
|
$2,400,000
$4.5 P/Share
|
|
Jan 20
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 20
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,460,280
+8.28%
|
$4,380,840
$3.42 P/Share
|
|
Dec 28
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,271
+14.52%
|
$65,271
$1.34 P/Share
|
|
Dec 23
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
900
-0.28%
|
$1,800
$2.55 P/Share
|
|
Dec 23
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,237
+0.39%
|
$1,237
$1.34 P/Share
|
|
Dec 22
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
7,652
-2.35%
|
-
|
|
Dec 22
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,516
+3.12%
|
$10,516
$1.34 P/Share
|
|
Dec 21
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
35,148
-5.08%
|
$70,296
$2.54 P/Share
|
|
Dec 21
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,976
+12.03%
|
$47,976
$1.34 P/Share
|
|
Dec 11
2020
|
Mitchell S Levine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,121
+17.81%
|
-
|
|
Dec 11
2020
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,909
+1.91%
|
-
|
|
Dec 11
2020
|
Cavan M. Redmond Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,416
+20.63%
|
-
|
|
Dec 11
2020
|
Albert P Parker COO |
BUY
Grant, award, or other acquisition
|
Direct |
5,586
+34.54%
|
-
|
|
Dec 11
2020
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
5,317
+50.0%
|
-
|
|
Dec 11
2020
|
Padmavathi Sundar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,177
+50.0%
|
-
|
|
Dec 11
2020
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,184
+41.12%
|
-
|
|
Dec 11
2020
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,602
+7.89%
|
-
|
|
Dec 11
2020
|
Lyndal K. Hesterberg CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,603
+46.9%
|
-
|
|
Apr 24
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 24
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,050,000
+6.66%
|
$2,100,000
$2.27 P/Share
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,391,466
+4.96%
|
$2,782,932
$2.16 P/Share
|